SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 111.89 |
Enterprise Value ($M) | 49.07 |
Book Value ($M) | 48.95 |
Book Value / Share | 1.28 |
Price / Book | 2.29 |
NCAV ($M) | 47.72 |
NCAV / Share | 1.25 |
Price / NCAV | 2.34 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.31 |
Return on Assets (ROA) | -0.78 |
Return on Equity (ROE) | -0.90 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.97 |
Current Ratio | 3.97 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 63.81 |
Assets | 65.05 |
Liabilities | 16.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Balyasny Asset Management Llc | 8.06 | ||
13D/A | Beigene, Ltd. | 3.17 | -90.00 | |
13G | Samsara BioCapital, L.P. | 6.40 | ||
13G | Gilead Sciences Inc | 13.90 | ||
13G/A | Perceptive Advisors Llc | 4.00 | -84.12 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
68,705 | 209,412 | 32.81 | |
103,226 | 373,123 | 27.67 | |
24,472 | 341,606 | 7.16 | |
(click for more detail) |
Similar Companies | |
---|---|
LIPO – Lipella Pharmaceuticals Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
LPCN – Lipocine Inc. | LQDA – Liquidia Corporation |
LSTA – Lisata Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io